Pain is indelibly associated with the cancer experience. A systematic review and meta-analysis indicate that the prevalence of cancer pain is 55% during anticancer treatment, 66.4% in advanced, metastatic, or terminal disease, and 39.3% after curative treatment.
CITATION STYLE
Copenhaver, D. J., Huang, M., Singh, J., & Fishman, S. M. (2021). History and Epidemiology of Cancer Pain. In Cancer Treatment and Research (Vol. 182, pp. 3–15). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/978-3-030-81526-4_1
Mendeley helps you to discover research relevant for your work.